Earnings · China A-shares
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. Class A (688621) earnings
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit -121.15% year on year, -122.10% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -2.71% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -121.15%
- Excl. one-offs YoY
- -122.10%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.46% | — |
| 3 days | -2.71% | — |
| 7 days | -4.24% | — |
| 14 days | -4.46% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +3.24%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | -¥34.54M | -121.15% | — | -24.60% | -0.31 | -2.84% | -2.71% | — | — |
| 2026 interim report | 2026-08-29 | -¥24.40M | -118.79% | — | -27.81% | -0.22 | -2.00% | +11.39% | -3.68% | +5.66% |
| 2026 Q1 report | 2026-04-24 | ¥20.63M | -30.25% | -4.21% | -14.62% | 0.18 | 1.67% | -4.61% | -16.37% | -16.79% |
| 2025 annual report | 2026-04-24 | ¥203.87M | +14.91% | +16.05% | +13.33% | 1.86 | 18.36% | -4.61% | -16.37% | -16.79% |
| 2025 Q3 report | 2025-10-30 | ¥163.29M | -21.38% | -23.89% | -6.65% | 1.49 | 14.95% | +0.31% | +16.94% | +21.69% |
| 2025 interim report | 2025-08-29 | ¥129.83M | -12.61% | -16.29% | +4.87% | 1.18 | 11.14% | +5.48% | -15.36% | -16.64% |
| 2025 Q1 report | 2025-04-25 | ¥29.58M | -59.34% | -69.67% | -8.49% | 0.27 | 2.81% | +0.00% | +13.57% | +10.33% |
| 2024 annual report | 2025-04-09 | ¥177.41M | -3.98% | -8.31% | +15.70% | 1.58 | 17.21% | +12.81% | +33.66% | +26.78% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.